Literature DB >> 19460257

Classifying the severity of COPD: are the new severity scales better than the old?

Cristóbal Esteban1, J M Quintana, M Egurrola, J Moraza, M Aburto, J Pérez-Izquierdo, L V Basualdo, A Capelastegui.   

Abstract

BACKGROUND: Forced expiratory volume in 1 second cut-off points establish the severity of chronic obstructive pulmonary disease (COPD).
OBJECTIVES: To compare how the American Thoracic Society (ATS), the British Thoracic Society (BTS), the Global Initiative for COPD (GOLD) and the ATS-European Respiratory Society (ATS-ERS) guidelines for rating COPD severity predict several significant outcomes.
DESIGN: Five-year prospective cohort study. Spirometry was performed and health-related quality of life (HRQoL) assessed using the Short Form 36 Health Survey and the Saint George's Respiratory Questionnaire. Hospital admissions resulting from COPD exacerbation and mortality during a 5-year follow-up period were recorded.
RESULTS: In all guidelines, the number of admissions was directly associated with COPD severity. The sensitivity and specificity for 5-year respiratory mortality were respectively 0.21 and 0.97 for the GOLD/ATS-ERS, 0.51 and 0.79 for the BTS, and 0.37 and 0.89 for the ATS guidelines. A similar pattern was seen for all-cause mortality. For HRQoL, statistically significant differences between guidelines were seen only for the BTS and ATS scales.
CONCLUSIONS: These guidelines did not consistently stratify patients with regard to 5-year mortality and HRQoL. Although the BTS system was slightly superior, none of the guidelines were closely related to these outcomes. Other instruments are needed for a better determination of the severity of COPD.

Entities:  

Mesh:

Year:  2009        PMID: 19460257

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  [Lung function test in advanced age].

Authors:  Helmut Frohnhofen; Jeanina Schlitzer; Sven Stieglitz
Journal:  Z Gerontol Geriatr       Date:  2022-09-15       Impact factor: 1.292

Review 2.  A Systematic Literature Review of the Humanistic Burden of COPD.

Authors:  John R Hurst; Mohd Kashif Siddiqui; Barinder Singh; Precil Varghese; Ulf Holmgren; Enrico de Nigris
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-05-10

3.  Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease.

Authors:  Toru Oga; Mitsuhiro Tsukino; Takashi Hajiro; Akihiko Ikeda; Koichi Nishimura
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-10-11

4.  Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease.

Authors:  Geetanjali Bade; Meraj Alam Khan; Akhilesh Kumar Srivastava; Parul Khare; Krishna Kumar Solaiappan; Randeep Guleria; Nades Palaniyar; Anjana Talwar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-08-05

5.  Body mass index, airflow obstruction and dyspnea and body mass index, airflow obstruction, dyspnea scores, age and pack years-predictive properties of new multidimensional prognostic indices of chronic obstructive pulmonary disease in primary care.

Authors:  Khalid Ansari; Niall Keaney; Andrea Kay; Monica Price; Joan Munby; Andrew Billett; Sharon Haggerty; Ian K Taylor; Hajed Al Otaibi
Journal:  Ann Thorac Med       Date:  2016 Oct-Dec       Impact factor: 2.219

6.  Clinical and functional correlations of the difference between slow vital capacity and FVC.

Authors:  Jonathan Jerias Fernandez; Maria Vera Cruz de Oliveira Castellano; Flavia de Almeida Filardo Vianna; Sérgio Roberto Nacif; Roberto Rodrigues Junior; Sílvia Carla Sousa Rodrigues
Journal:  J Bras Pneumol       Date:  2019-12-20       Impact factor: 2.624

7.  Association between Severity of Chronic Obstructive Pulmonary Disease and Lung Function Tests.

Authors:  Hamid Reza Jamaati; Bahareh Heshmat; Ronak Tamadon; Abbas Hamidi Rad; Seyed Amir Mohajerani; Golnar Radmand; Seyed Mohammad Reza Hashemian
Journal:  Tanaffos       Date:  2013
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.